^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    LM103

    i
    Other names: LM103, Autologous tumor infiltrating lymphocytes
    Associations

    News

    Trials
    Company:
    Blue Horse Medical
    Drug class:
    Immunostimulant
    Related drugs:
    Associations

    News

    Trials
    2d
    An Exploratory Clinical Study to Evaluate the Safety, Tolerability, Immune Response and Preliminary Efficacy of LM103 Injection in Combination With PD-1 in Patients With Advanced Solid Tumours (clinicaltrials.gov)
    P1, N=10, Recruiting, Suzhou BlueHorse Therapeutics Co., Ltd.
    New P1 trial • Combination therapy • Metastases
    |
    cyclophosphamide • LM103
    over1year
    A Clinical Study on LM103 for the Treatment of Advanced Solid Tumors (clinicaltrials.gov)
    P1, N=5, Recruiting, Suzhou BlueHorse Therapeutics Co., Ltd.
    New P1 trial • Metastases
    |
    CD8 (cluster of differentiation 8) • MUC16 (Mucin 16, Cell Surface Associated) • CD4 (CD4 Molecule)
    |
    cyclophosphamide • LM103